fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
News

Fusion prostate biopsy – smart test for prostate cancer now available at Sheba

fusion prostate biopsy

A prostate biopsy is recommended in case of suspected prostate cancer due to increased PSA levels or an abnormal rectal examination, or both.

A fusion biopsy is a smart biopsy guided by MRI scanning. During the test, suspicious areas are noted by the radiologist, and the MRI data is combined with ultrasound images. This combination (fusion) makes it possible to target the biopsy more accurately to suspicious areas, rather than blind piercing, and to increase the rate of disease detection.

The biopsy is managed by a urologist, who takes a small tissue sample from the prostate using a small needle. Then, a tissue sample is sent to the pathological laboratory for microscopic examination.

Who should undergo a fusion biopsy?

Leading HMOs in the United States and Europe recommend to undergo an MRI-guided biopsy in all cases where a re-biopsy is necessary. It means that the patient has already undergone a prostate biopsy with normal results, but it is necessary to repeat the procedure because of the alleged disease or in case of follow-up. Patients with an enlarged prostate or with a high suspicion of cancer who have not previously undergone a prostate biopsy can also use this method.

Related
Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More